超声造影在移植肝脏局灶性低回声病灶鉴别诊断中的应用

 目的 评价超声造影技术在肝移植术后肝脏局灶性低回声病灶鉴别诊断中的应用价值.方法 对肝移植术后肝脏出现局灶性低回声病灶患者,用西门子 Sequoia512彩色多普勒超声诊断仪和超声造影剂Sonovue进行超声造影检查,观察3个时相的造影剂灌注模式,并用自动跟踪对比量化技术(Axius ACQ)对病灶及周围肝组织进行定量分析.结果 10例出现局灶性低回声病灶的患者中,超声造影明确诊断梗死灶5例(低回声病灶为无增强,ACQ分析无造影剂灌注),非均质脂肪肝3例(低回声病灶在动脉相、门脉相呈高增强,ACQ分析该区域为正常肝组织,周围肝组织为血流灌注不良区域),肝癌复发2例(其特征为动脉相快速均匀高增强,门脉相及延迟相快速消退).结论 超声造影技术能较好评估肝实质的血流灌注分布情况,有助于移植肝脏梗死灶、非均质性脂肪肝及肿瘤复发的鉴别诊断.     

Diagnostic accuracy of two-dimensional shear wave elastography for the non-invasive staging of hepatic fibrosis in chronic hepatitis B: a cohort study with internal validation

Objectives

To determine the accuracy of two-dimensional shear wave elastography (2D-SWE) for noninvasive staging of hepatic fibrosis in chronic hepatitis B (CHB).

Methods

Patients with CHB infection who underwent liver biopsy were consecutively included. Receiver-operating characteristic (ROC) curves were constructed to assess the overall accuracy and identify optimal cutoff values.

Results

Three hundred three patients were analysed. The diagnostic performance characteristics were determined for the first 202 patients (the index cohort) and were validated on the next 101 patients (validation cohort). The areas under the ROC curves for significant fibrosis, severe fibrosis and cirrhosis were all greater than 0.90 and did not differ significantly between the index and validation cohorts. Using the cutoff values generated from the index cohort, the validation cohort 2D-SWE had negative predictive values of 82.6 % (95 % confidence interval [CI]: 68.4 %???92.3 %) for significant fibrosis, 95.1 % (95 % CI: 86.3 %???99.0 %) for severe fibrosis and 97.4 % (95 % CI: 90.8 %???99.7 %) for cirrhosis. The positive predictive values were 83.6 % (95 % CI: 71.2 %???92.2 %), 65.0 % (95 % CI: 48.1???79.5 %) and 60.0 % (95 % CI: 38.7 %???78.9 %), respectively.

Conclusion

The 2D-SWE showed good diagnostic accuracy in staging liver fibrosis in patients with CHB infection and assisted in excluding liver fibrosis and cirrhosis.

Key Points

? Two-dimensional shear wave elastography showed good diagnostic accuracy in assessing liver fibrosis. ? Diagnostic performance did not differ significantly between the index and validation cohorts. ? Two-dimensional shear wave elastography assisted in excluding liver fibrosis and cirrhosis.     

肝脏局灶病变血供对表观扩散系数的影响

目的　研究肝脏局灶病变的血供对病灶表观扩散系数 (apparentdiffusioncoefficient,ADC)的影响。方法　研究对象包括 87例病人 ,共 1 59个肝脏局灶病变 ,采用不同的b值和b值差的扩散加权成像 (diffusion weightedimaging,DWI)技术对各病灶及肝脏、脾脏及胆囊进行ADC值的测量。结果小b值和b值差所检测到的ADC值受组织或病变内血流灌注的影响 ,海绵状血管瘤的平均ADC值最高 (7 64× 1 0 - 3mm2 /s) ,富血供恶性肿瘤的平均ADC值明显高于乏血供恶性肿瘤 (分别为 3 47×1 0 - 3mm2 /s和 2 39× 1 0 - 3mm2 /s,t=2 39,P <0 0 1 ) ,肝囊肿的ADC值几乎不受b值和b值差的影响。结论　当利用小b值和小b值差进行DWI时 ,组织或病变的ADC值受血流灌注的影响较大。DWI及ADC值测量可在一定程度上反映肝脏局灶病变的血供     

DWI结合LAVA技术在肝脏占位性病变中的应用价值

目的：探讨联合运用DWI和LAVA技术在肝脏占位性病变的诊断价值。方法：回顾性分析经手术病理证实的60例肝脏占位性病变（小肝癌30例、肝血管瘤15例、肝囊肿15例）的MRI图像。扫描序列为常规自旋回波序列（T2WI、T1WI）、LAVA多期增强序列及DWI检查（b值分别为0和800 s/mm^2）。比较小肝癌、肝血管瘤、肝囊肿的ADC值是否有差异;对比分析LAVA多期增强序列（A组）、T1WI、T2WI和DWI（B组）及这2种方法联合应用（C组）在病变检出和定性诊断方面的价值。结果：在病变检出方面：A组检出67个病灶,B组检出67个,C组检出67个,A组与C组比较,对病变的检出率无差异。在结节的定性诊断方面：在取得临床或病理证实的67个病灶中,A组诊断正确57个（85.1%）,C组为65个（97%）,2组间差异有显著性意义（χ2=5.858,P〈0.05）;肝囊肿、肝血管瘤、小肝细胞癌的ADC值分别为（3.341±0.299）×10-3mm^2/s、（2.154±0.308）×10-3mm^2/s、（1.132±0.241）×10-3mm^2/s。结论：DWI结合LAVA技术对肝脏小病灶的定性诊断具有重要的临床应用价值。     

Clinical value of MRI liver-specific contrast agents: a tailored examination for a confident non-invasive diagnosis of focal liver lesions

Screening of the liver for hepatic lesion detection and characterization is usually performed with either ultrasound or CT. However, both techniques are suboptimal for liver lesion characterization and magnetic resonance (MR) imaging has emerged as the preferred radiological investigation. In addition to unenhanced MR imaging techniques, contrast-enhanced MR imaging can demonstrate tissue-specific physiological information, thereby facilitating liver lesion characterization. Currently, the classes of contrast agents available for MR imaging of the liver include non-tissue-specific extracellular gadolinium chelates and tissue-specific hepatobiliary or reticuloendothelial agents. In this review, we describe the MR features of the more common focal hepatic lesions, as well as appropriate imaging protocols. A special emphasis is placed on the clinical use of non-specific and liver-specific contrast agents for differentiation of focal liver lesions. This may aid in the accurate diagnostic workup of patients in order to avoid invasive procedures, such as biopsy, for lesion characterization. A diagnostic strategy that considers the clinical situation is also presented.     

T2-weighted breath-hold MRI of the liver at 1.0 T: Comparison of turbo spin-echo and HASTE sequences with and without fat suppression

To compare the clinical usefulness of T2-weighted breath-hold sequences for imaging the liver, 33 patients with 97 focal hepatic lesions were studied with a 1.0-T scanner by using T2-weighted breath-hold turbo spin-echo (SE) sequences and T2-weighted breath-hold half-Fourier single-shot turbo SE (HASTE) sequences with and without fat suppression. Images were quantitatively analyzed for liver signal-to-noise ratio (SNR) and lesion-to-liver contrast-to-noise ratios (CNR). Qualitative analysis was performed for lesion conspicuity, motion artifacts, and anatomic sharpness of extrahepatic structures. Breath-hold turbo SE imaging with fat suppression showed the highest CNR for cystic lesions and the best lesion conspicuity for cystic and solid lesions among the four sequences. For solid lesions, there was no significant difference of lesion-to-liver CNR between them. HASTE sequence was superior to turbo SE sequences in terms of motion artifacts; however, the usefulness for evaluating focal hepatic lesions was limited compared with turbo SE sequence with fat suppression. Addition of fat suppression was not helpful for HASTE imaging because of decreased lesion conspicuity and extrahepatic details without the advantage of reducing motion artifacts. This study suggests that turbo SE sequence with fat suppression is most useful for breath-hold T2-weighted liver imaging at 1.0 T. Addition of imaging without fat suppression can be considered for evaluating extrahepatic structures. HASTE sequence may have a role for imaging uncooperative patients due to absence of motion artifacts.     

八次激发SE-EPI在肝脏MRI的应用

目的；比较八次激发SE－EPI与呼吸门控FSE及SSFSE T2WI在肝脏的应用。方法：对14例志愿者及21例肝病患者行上腹部呼吸门控FSE及SSFSE和屏气八次激发SE－EPI扫描。所有T2WI序列均运用脂肪抑制技术。定量分析肝脏、病灶的信噪比及肝脏－病灶的对比噪声比，评价各序列的图像质量及伪影。结果：八次激发SE－EPI与SSFSE及FSE在肝脏及病灶信噪比，肝脏－病灶对比度噪声比和图像质量方面无明显差异（P＞0．05）。其磁敏感伪影较FSE及SSFSE重（P＜0．01），SE－EPI化学位移伪影与SSFSE及FSE相比无明显差别（P＞0．05）。SE－EPI及FSE运动伪影明显比SSFSE重（P＜0．01），但SE－EPI运动伪影与FSE相比无明显差别（P＞0．05）。SE－EPI与FSE及SSFSE的图像质量无明显差别（P＞0．05）。结论：八次激发SE－EPI能够在较短时间里提供较高质量的上腹部T2WI。被检查者在扫描时可自由平静呼吸或屏气，可作为肝脏T2WI的补充序列。     

Which are the cut-off values of 2D-Shear Wave Elastography (2D-SWE) liver stiffness measurements predicting different stages of liver fibrosis,considering Transient Elastography (TE) as the reference method?

Introduction

To identify liver stiffness (LS) cut-off values assessed by means of 2D-Shear Wave Elastography (2D-SWE) for predicting different stages of liver fibrosis, considering Transient Elastography (TE) as the reference method.

Methods

Our prospective study included 383 consecutive subjects, with or without hepatopathies, in which LS was evaluated by means of TE and 2D-SWE. To discriminate between various stages of fibrosis by TE we used the following LS cut-offs (kPa): F1-6, F2-7.2, F3-9.6 and F4-14.5.

Results

The rate of reliable LS measurements was similar for TE and 2D-SWE: 73.9% vs. 79.9%, p = 0.06. Older age and higher BMI were associated for both TE and 2D-SWE with the impossibility to obtain reliable LS measurements. Reliable LS measurements by both elastographic methods were obtained in 65.2% of patients. A significant correlation was found between TE and 2D-SWE measurements (r = 0.68). The best LS cut-off values assessed by 2D-SWE for predicting different stages of liver fibrosis were: F ≥ 1: >7.1 kPa (AUROC = 0.825); F ≥ 2: >7.8 kPa (AUROC = 0.859); F ≥ 3: >8 kPa (AUROC = 0.897) and for F = 4: >11.5 kPa (AUROC = 0.914).

Conclusions

2D-SWE is a reliable method for the non-invasive evaluation of liver fibrosis, considering TE as the reference method. The accuracy of 2D-SWE measurements increased with the severity of liver fibrosis.     

Hepatic T2-weighted MRI: A prospective comparison of sequences,including breath-hold,half-Fourier turbo spin echo (HASTE)

The purpose of this study was to quantitatively compare the hepatic contrast characteristics of conventional spin-echo (CSE) and fast spin-echo (FSE) sequences with breath-hold T2-weighted images acquired with half-Fourier turbo spin echo (HASTE). Forty-five patients were examined with a phased-array surface coil. Nineteen patients had focal hepatic lesions, including eight malignant tumors, 10 cavernous hemangiomas, and one hepatic adenoma. Twenty-six patients had no focal hepatic lesions. T2-weighted images with comparable TE were acquired with CSE, FSE, and HASTE pulse sequences. Signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) for liver, spleen, and lesions were measured. FSE demonstrated significantly better quantitative performance than CSE for liver-spleen CNR (P = .0084). No statistically significant difference was demonstrated between FSE and CSE for liver or spleen SNR. FSE demonstrated clear scan time and resolution advantages over CSE. HASTE performed significantly poorer than CSE and FSE for liver-spleen CNR (P < .0001), liver SNR (P = .0002 for CSE and P < .0001 for FSE), and spleen SNR (P < .0001). Optimized FSE images with a short echo train length performed comparably to CSE images of equivalent TE. Liver-lesion CNR was suppressed on HASTE images, suggesting that long echo train length FSE sequences could diminish solid lesion detection compared to CSE and short echo train length FSE.     

探讨双b值对比法在肝脏局灶性病变诊断中的作用

目的：探讨双b值对比法在肝脏局灶性病变诊断中的价值.方法：回顾性分析108例行肝脏MRI平扫及动态增强扫描患者的病例（肝癌44例.转移瘤4例,血管瘤40例,囊肿18例,局灶性结节增生2例）,分为良恶性两组（恶性组48例,A组;良性组60例,B组）.均行b值为500和800 s/mm2的DWI扫描,测量肝脏病变的信号强度值,计算相对信号比R500、R800（R=病灶信号/背景信号）,观察不同b值时病变的信号变化情况△R（△R=R800-R500）.采用X2检验分析采用△R值诊断良恶性病变与病理结果的一致性.结果：△R≥0.25有42例（PA组）,△R〈0.25（PB组）有66例,其中PA中有4个为良性病变（均为血管瘤）,PB中有10个为恶性病变（2个转移瘤,8个肝癌）,差异无统计学意义（X2=1.786,P〉0.05）.结论：双b值对比法在肝脏局灶性病变的定性诊断中具有可行性.     

常规SE序列和动态增强MRI诊断肝局灶性病变的比较

目的比较常规SE序列与动态Gd-U．----x增强扫描对肝局灶病变的诊断价值。方法对34例肝局灶病变做了常规SE平扫和动态Gd-U．---A增强及延迟万WI增强扫描；就各序列对肝局灶病变的检出率、病变的信噪比（C／N）值和图像质展进行定员和定性分析。结果36例共142个病灶，动态Gd-lyl？l？A检出率（138／142，958％）明st高于IFZWI和延迟TW［增强（128／14，叨％；119／142，838％）（P＜005）：动态Gd-IJ：1713A增强的C／N值高于TZWI和TIWI延迟增强（P＜0．05）；动态增强的伪影较L们少（P＜0．01），而病灶清晰度各序列之间无明显差别（P＞0．历）。结论动态u-ly：1717A增强扫描在病灶检出率、图像质显反C／N值方面均优于IWI，对肝局灶病变的诊断是一种有价值的方法，     

Focal hepatic lesions: differentiation with MR imaging at 0.5 T

Magnetic resonance (MR) examinations of 43 patients with 95 focal hepatic lesions (diameter, greater than 1 cm) were analyzed for lesion shape, homogeneity, and relative signal intensity compared with normal liver parenchyma, spleen, and skeletal muscle. On T1-weighted, balanced, and T2-weighted images, most metastases (74%), cavernous hemangiomas (76%), and cysts (82%) were smooth and round or oval, while the hepatocellular carcinomas all had irregular borders (40%) or were lobulated (60%). All lesions with irregular borders were malignant. Seventy percent of metastatic lesions, 85% of cavernous hemangiomas, and 100% of simple hepatic cysts were of homogeneous signal intensity, while 60% of hepatocellular carcinomas were inhomogeneous. Logistic regression analysis of multiple lesion characteristics showed that inhomogeneous lesions had a high likelihood of malignancy, while markedly hyperintense lesions had a very low probability of being malignant, regardless of other traits. Homogeneous lesions that were isointense or hyperintense compared with spleen on balanced images but were not markedly hyperintense on T2-weighted images also had a high likelihood of malignancy.     

Hepatic focal nodular hyperplasia: MR imaging at 1.0 and 1.5 T.

Ten cases of hepatic focal nodular hyperplasia (FNH) were studied with magnetic resonance (MR) imaging. Proof of diagnosis was by needle biopsy or follow-up of as long as 5 years. Both short TR/TE and long TR/TE images were obtained. The most common finding was isointensity of the lesion relative to liver parenchyma with all pulse sequences. A central scar was seen in only one patient and was hyperintense on long TR/TE images. Slight hyperintensity of the lesion on short TR/TE and long TR/TE images was seen in two cases. Textural heterogeneity was present in only one of these. The most common presentation in our series was a visually isointense lesion relative to liver on short TR/TE images and an isointense or slightly hyperintense lesion on long TR/TE images. A review of the literature and the present findings suggest that FNH has a variable appearance on MR images.     

同相位与反相位梯度回波T_1WI在肝脏的应用价值

目的　评估同相位与反相位梯度回波T1WI在肝脏应用的价值 ,尤其是评估其对肝内脂肪变的检测能力。方法　 76例病人采用屏气同相位与反相位T1W梯度回波序列对肝脏扫描。将76例病人分成 3组分析 :(1)肝内无占位病变组 ,8例 ;(2 )肝癌组 ,34例 ;(3)血管瘤或囊肿组 ,共 34例。对 2种序列的图像进行了定量分析。结果　 76例中发现 14例肝脂肪变 ,6 2例无脂肪变。在 14例肝脂肪变中 ,反相位MRI还显示了 4例低信号肿块周边环状高信号带 ,其中 3例肝癌 ,1例血管瘤。在肝脂肪变的反相位上显示肝与脾和病灶信噪比或对比信噪比值较同相位低 ,但肝与脾和病灶间信噪比 (SNR)或对比信噪比 (CNR)在同相位与反相位上均无显著性差异 (P >0 .0 5 )。结论　同相位与反相位对显示肝脏病变和对脂肪成分的诊断是有价值的。两者互补 ,缺一不可。为避免肝脏病变在T1WI上的误诊或漏诊 ,建议常规行同相位与反相位T1W扫描     

Initial clinical experience with oral manganese (CMC-001) for liver MR imaging

Recently, a new oral liver-specific manganese-based MR agent (CMC-001) has been introduced. This contrast medium is delivered to the liver in high concentrations in the portal vein and very low doses in the hepatic artery, as only small amounts of manganese enter the general circulation. It is taken up by the hepatocytes and excreted in the bile. Our initial experience with the new MR contrast medium in a variety of patients is reported. A total of 20 patients (11 males and 9 females) were studied with MR imaging 2 h after oral ingestion of the contrast agent. Sixteen patients were referred for evaluation of focal liver lesion(s), whereas in the remaining four patients, evaluation of the biliary tract was requested. In the 17 patients without biliary obstruction, there was an increased signal intensity of the liver parenchyma, whereas in the three patients with biliary obstruction, the uptake was delayed. There was excellent visualization of the biliary system on the T1-weighted images in the 16 patients without biliary obstruction referred for evaluation of a focal liver lesion. In seven patients, the uptake was patchy. In patients with focal liver lesions or biliary tract diseases, it is possible to increase the signal intensity of the liver parenchyma after the oral intake of CMC-001. In patients without biliary tract obstruction, the biliary system is easily visualized. Oral manganese seems to be useful in hepatobiliary MRI. Further research is strongly warranted. Financial disclosure: Thomsen HS. Manganese-containing magnetic resonance contrast agent. US patent no. 6,015,545/ 18 January 2000.     

The value of respiratory triggered T2-weighted turbo spin-echo imaging of the liver using a phased array coil

The purpose of this study was to evaluate the value of the respiratory triggered turbo spin-echo (TSE) technique for T2-weighted MRI of liver lesions. Fifty-nine patients (32 men, 27 women; mean age, 63.3 years) with focal hepatic lesions were prospectively studied with MRI at 1.5 T with use of a body phased array coil. In the first 15 patients, breath-hold TSE, respiratory triggered TSE, and conventional nonrespiratory triggered TSE T2-weighted imaging were compared. Because nonrespiratory triggered TSE imaging was significantly inferior (P < .01) to breath-hold or respiratory triggered images, breath-hold and respiratory triggered TSE T2-weighted images were compared in the remaining 44 patients. Images were analyzed quantitatively by measuring the liver signal-to-noise ratio and the lesion-liver and spleen-liver contrast-to-noise ratios and qualitatively by evaluating the lesion conspicuity, liver parenchymal homogeneity, and sharpness of intrahepatic vessels. The imaging time was 26 seconds for breath-hold TSE imaging, 49 to 219 seconds (mean, 149 seconds) for the respiratory triggered TSE imaging, and 79 to 379 seconds (mean, 239 seconds) for the nonrespiratory triggered TSE imaging. Quantitatively, the signal-to-noise ratio of the liver for breath-hold imaging was comparable to that for respiratory triggered imaging. The lesion-liver and liver-spleen contrast-to-noise ratios for the respiratory triggered images were greater by 37% and 39%, respectively, than for the breath-hold T2-weighted TSE images. Qualitatively, the respiratory triggered images showed lower frequency of image artifact, better lesion conspicuity, and greatly superior depiction of intrahepatic structures compared with the breath-hold T2-weighted TSE images. The respiratory triggered T2-weighted TSE technique provides better quality liver images than the breath-hold TSE technique or nonrespiratory triggered technique within a reasonable acquisition time.     

超顺磁性氧化铁诊断肝脏小病灶的临床应用价值初探

目的：探讨超顺磁性氧化铁（商品名为菲立磁,Feridex)对肝脏小病灶的临床应用价值,以及滴注后的最佳扫描时间。方法：17例经B超或CT检查发现肝脏内小病灶患者,经常规MR平扫和增强扫描1－3d后,经静脉滴注菲立 （0.05ml/kg),并于0.5,3.6h后进行扫描。主观目测菲立磁增强后肝脏小病灶的显示情况,定量分析菲立磁增强后肝脏信号下降情况。结果;菲立磁增强后扫描可显著肝脏内直径小于1cm的病灶21个,明显多于常规MR检查（8个）。菲立磁应用后小肝癌和容易与肝癌混淆的局灶性结节增生和再生结节信号变化明显不同。菲立磁增强后扫描,肝脏T2WI,T1WI信号均较增强前下降（P＜0．01）,滴注菲立磁后0.5,3,6h扫描,T2WI各时间点的脏脏信号下降统计学上差异无显著性意义（P＞0．05）。结论：菲立磁能显著提高肝脏小病灶的检出率,而且对肝脏小病灶的鉴别诊断可提供有利的依据。     

Gadobenate dimeglumine-enhanced liver MR imaging: value of dynamic and delayed imaging for the characterization and detection of focal liver lesions

The aim of this study was to determine the value of delayed-phase imaging (DPI) of gadobenate dimeglumine (Gd-BOPTA)-enhanced MR imaging for the evaluation of focal hepatic tumors compared with precontrast imaging and early dynamic phase imaging. The MR images were obtained in 48 patients with 98 focal hepatic tumors. Three-dimensional gradient-echo (GRE) imaging obtained before and 30, 60, and 1 h after administration of 0.1 mmol/kg of gadobenate dimeglumine. Each image set was analyzed qualitatively (lesion detection, conspicuity, delineation, and enhancement pattern on DPI) and quantitatively [signal-to-noise ratio (SNR), tumor–liver contrast-to-noise ratio (CNR)]. Improved lesion-to-liver contrast during the dynamic phase imaging was observed compared with precontrast images. The DPI showed a homogeneous enhancement of liver parenchyma and distinctive enhancement features of focal liver lesions: metastases (85%) showed a target shaped enhancement, and hepatocellular carcinomas (HCCs) showed an inhomogeneous (58%) or homogeneous enhancement (21%). The DPI showed better performance for the detection of metastases than other images by increasing lesion delineation (p<0.05). The absolute CNR of metastasis measured from periphery of the tumors on DPI was greater than precontrast and arterial phase imaging (p<0.05). The Gd-BOPTA during both dynamic and delayed phases provides valuable information for the characterization of focal liver lesions, and furthermore, Gd-BOPTA-enhanced DPI contributed to the improved detection of liver metastasis compared to precontrast and early dynamic imaging.     

经量化的扩散加权成像对肝脏占位性病变的鉴别诊断价值

目的：探讨经量化的扩散加权成像(DWI)在肝脏占位性疾病影像诊断中的价值。方法本组回顾性分析120例肝脏占位性病变患者及对照组12例正常肝脏的影像资料,应用3.0T MR 行常规 MR 及 DWI,120例患者共检出179个病灶(其中53个肝癌、61个转移瘤、32个肝血管瘤及33个肝囊肿),分析其与对照组的 DWI 图及表观扩散系数(ADC)图,并测量 ADC 值,比较其间是否存在统计学差异。结果本组研究 b 值选择800 s/mm2,(1)其中33个肝囊肿呈低信号,51个肝癌、61个肝转移瘤及32个肝血管瘤呈高信号,肝囊肿的 DWI 图像信号与肝癌、肝转移瘤及肝血管瘤有显著性差异(P <0.05);(2)肝癌、肝转移瘤 ADC 伪彩图大体呈冷色系表现,肝囊肿、肝血管瘤 ADC 伪彩图大体呈暖色系表现;(3)肝癌、肝转移瘤、肝血管瘤、肝囊肿平均 ADC 值相互间行两两比较,总体上存在统计学差异(P <0.05),但肝癌与肝转移瘤之间两两比较,无统计学差异(P >0.05),通过结合背景肝,比较肝癌的病灶/背景肝 ADC 值与肝转移瘤的病灶/背景肝 ADC 值,二者差异有显著性(P <0.05)。结论DWI 和 ADC 图分析及ADC 值测量可为肝脏占位性病的诊断及鉴别诊断提供重要的补充信息。     

Invited MRI of the liver

MRI of the liver is a powerful imaging modality for detection and characterization of liver pathology. MRI technology continues to evolve with developments in scanner hardware performance and refinements in imaging sequences, particularly in respect to fast imaging techniques, improving the quality of images that can be routinely achieved. Fast imaging techniques allow dynamic contrast-enhanced scanning to assist in lesion detection and characterization. An array of tissue-specific contrast agents are also becoming available; the clinical utility of some of these agents is yet to be fully established. An overview of scanning technique, contrast media, and the role of MRI in liver lesion detection and characterization is presented, with a review of the typical imaging characteristics of common focal and diffuse hepatic diseases. Where possible, emphasis has been placed on features that allow distinction between the various pathologic entities described.